MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 93 filers reported holding MINERVA NEUROSCIENCES INC in Q4 2019. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,417,000 | -16.3% | 760,000 | -5.0% | 0.06% | -27.2% |
| Q2 2020 | $2,888,000 | -52.0% | 800,000 | -20.0% | 0.08% | -68.1% |
| Q1 2020 | $6,020,000 | -15.3% | 1,000,000 | 0.0% | 0.25% | -7.6% |
| Q4 2019 | $7,110,000 | -8.3% | 1,000,000 | 0.0% | 0.28% | -11.6% |
| Q3 2019 | $7,750,000 | +313.3% | 1,000,000 | +233.3% | 0.31% | +1252.2% |
| Q1 2018 | $1,875,000 | +23.4% | 300,000 | +19.4% | 0.02% | 0.0% |
| Q4 2017 | $1,520,000 | -20.4% | 251,300 | 0.0% | 0.02% | -30.3% |
| Q3 2017 | $1,910,000 | -14.1% | 251,300 | 0.0% | 0.03% | -15.4% |
| Q2 2017 | $2,224,000 | +9.2% | 251,300 | 0.0% | 0.04% | -13.3% |
| Q1 2017 | $2,036,000 | -31.1% | 251,300 | 0.0% | 0.04% | -31.8% |
| Q4 2016 | $2,953,000 | +4.6% | 251,300 | +25.6% | 0.07% | +17.9% |
| Q3 2016 | $2,823,000 | – | 200,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,652,436 | $31,166,000 | 4.20% |
| NEXTHERA CAPITAL LP | 492,958 | $5,792,000 | 3.40% |
| Iguana Healthcare Management, LLC | 150,000 | $1,763,000 | 1.05% |
| Perceptive Advisors | 810,537 | $9,523,000 | 0.68% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,141,333 | $13,411,000 | 0.63% |
| FEDERATED HERMES, INC. | 6,358,642 | $74,714,000 | 0.22% |
| EAM Investors, LLC | 137,685 | $1,618,000 | 0.22% |
| Orbimed Advisors | 556,200 | $6,535,000 | 0.08% |
| J. Goldman & Co LP | 103,281 | $1,214,000 | 0.08% |
| Virtus ETF Advisers LLC | 18,814 | $221,000 | 0.07% |